Dr. Mack's research has focused primarily on the use of novel antitumor agents in
human estrogen receptor negative
breast tumor cells, and more recently, on the use of bioflavonoids in the regulation of estrogen receptor
positive (ER +) and estrogen receptor negative (ER --RRB-
breast tumor cell proliferation.
Phytates have been shown to inhibit the growth of
human leukemia cells, colon cancer cells, both estrogen receptor -
positive and negative
breast cancer cells, voicebox cancer, cervical cancer, prostate cancer, liver
tumors, pancreatic, melanoma, and muscle cancers.